Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celera and Abbott Signs a Deal
Yahoo/Zacks.com
Thursday, September 23, 2010 - 6:53am
tags:
Celera, Abbott Laboratories
A Dendreon Deal: It's Not What You Think
Motley Fool
Wednesday, September 22, 2010 - 3:48pm
tags:
Dendreon, GSK, Provenge, prostate cancer
Lundbeck Is The Latest To Cut Jobs & Shift R&D
Pharmalot
Wednesday, September 22, 2010 - 3:42pm
tags:
R&D, layoffs, Lundbeck
J&J lawyers: FDA knew of secret 2009 Motrin recall
Yahoo/AP
Wednesday, September 22, 2010 - 3:40pm
tags:
Motrin, FDA, JNJ, recalls
Abbott recalls infant formula on bug contamination
Abbott
Wednesday, September 22, 2010 - 2:13pm
tags:
infant formula, Abbott Laboratories, recalls
Professional Pharmaceutical Representative Compensation
Pharmareform
Wednesday, September 22, 2010 - 1:28pm
tags:
drug reps
Sanofi May Announce ‘Critical’ Diabetes Partnerships
Bloomberg
Wednesday, September 22, 2010 - 1:27pm
tags:
Sanofi, diabetes, partnerships
Endo pain drug formulation gets FDA priority review
Bizjournals.com
Wednesday, September 22, 2010 - 1:25pm
tags:
oxymorphone, FDA, Endo
Bristol-Myers To Pay $27M For Illegal Pricing
Pharmalot
Wednesday, September 22, 2010 - 11:42am
tags:
Bristol-Myers Squibb, settlements, Medicaid
Dendreon: Assessing New Threat to Provenge
TheStreet.com
Wednesday, September 22, 2010 - 11:40am
tags:
Provenge, Dendreon, vaccines, prostate cancer, AstraZeneca, zibotentan
Vical shares crushed by failed drug trial
Marketwatch
Wednesday, September 22, 2010 - 11:39am
tags:
Vical
Drug indexes gain as Biogen Idec slides
Marketwatch
Wednesday, September 22, 2010 - 11:38am
tags:
Biogen Idec, drug stocks
Will Johnson & Johnson Turnover Documents Today?
Pharmalot
Wednesday, September 22, 2010 - 10:09am
tags:
JNJ, recalls
Teva files new Copaxone lawsuit against Mylan
Yahoo/AP
Wednesday, September 22, 2010 - 10:08am
tags:
Teva Pharmaceuticals, Copaxone, patents, generics, MS, multiple sclerosis
Vivus Rallies on Positive Results for Obesity Drug
Seeking Alpha
Wednesday, September 22, 2010 - 10:06am
tags:
Vivus, obesity, Qnexa
Mylan Gets Order Blocking Glaxo Sale of Generic Paxil
Bloomberg
Wednesday, September 22, 2010 - 9:59am
tags:
Mylan, GSK, generics, Paxil, antidepressants
Takeda Seeks 10-Fold Jump in China Sales by 2015, Hasegawa Says
Bloomberg
Wednesday, September 22, 2010 - 9:58am
tags:
Takeda, China
Novartis Cushing's Drug Passes Late-Stage Test
TheStreet.com
Wednesday, September 22, 2010 - 9:58am
tags:
Novartis, Cushing's disease
Glaxo, Theravance report Relovair safety data
Yahoo/AP
Wednesday, September 22, 2010 - 9:57am
tags:
GSK, Theravance, asthma, lung disease, Relovair
Novartis gains FDA approval for Gilenya drug
Marketwatch
Wednesday, September 22, 2010 - 9:53am
tags:
FDA, Gilenia, Novartis, Gilenya, MS, multiple sclerosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.